TNF and metabolic syndrome: Accordingly, the rat model of T2DM exhibited dyslipidemia, insulin resistance, inflammatory response (TNF-α), and hepatic damage indicated by increased activity of serum transaminases and liver hypertrophy and apoptosis (increased gene expression of caspase-3).